Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHINE study: shorter treatment for minimal TB in children
ISRCTN63579542Phase 3Completed
- Sponsor
- University College London
- Start
- Jul 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of isoniazid, rifampicin, pyrazinamide and ethambutol in Tuberculosis (TB) (2 arms), sponsored by University College London. Primary endpoints: Unfavourable outcome and Grade 3/4 adverse events. Started Jul 2016; status: completed.
02
Drugs
isoniazidrifampicinpyrazinamideethambutol
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on ISRCTN63579542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63579542.